Doripenem: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 26: | Line 26: | ||
'''| [[Doripenem labels and packages|Labels and Packages]]''' | '''| [[Doripenem labels and packages|Labels and Packages]]''' | ||
== | ==Mechanism of Action== | ||
==References== | ==References== | ||
Revision as of 01:48, 26 December 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Doripenem is an ultra-broad spectrum injectable antibiotic. It is a beta-lactam and belongs to the subgroup carbapenem. It was launched byShionogi Co. of Japan under the brand name "Finibax" in 2005. It is particularly active against Pseudomonas aeruginosa.
Category
Carbapenem
US Brand Names
Doribax®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Overdosage | Clinical Studies | Dosage and Administration | Compatibility, Reconstitution, and Stability | Directions For Use | How Supplied | Labels and Packages